Increased Risk for Invasive Breast Cancer Associated with Hormonal Therapy: A Nation-Wide Random Sample of 65,723 Women Followed from 1997 to 2008
Open Access
- 6 October 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (10), e25183
- https://doi.org/10.1371/journal.pone.0025183
Abstract
Hormonal therapy (HT) either estrogen alone (E-alone) or estrogen plus progesterone (E+P) appears to increase the risk for breast cancer in Western countries. However, limited information is available on the association between HT and breast cancer in Asian women characterized mainly by dietary phytoestrogens intake and low prevalence of contraceptive pills prescription. A total of 65,723 women (20–79 years of age) without cancer or the use of Chinese herbal products were recruited from a nation-wide one-million representative sample of the National Health Insurance of Taiwan and followed from 1997 to 2008. Seven hundred and eighty incidents of invasive breast cancer were diagnosed. Using a reference group that comprised 40,052 women who had never received a hormone prescription, Cox proportional hazard models were constructed to determine the hazard ratios for receiving different types of HT and the occurrence of breast cancer. 5,156 (20%) women ever used E+P, 2,798 (10.8%) ever used E-alone, and 17,717 (69%) ever used other preparation types. The Cox model revealed adjusted hazard ratios (HRs) of 2.05 (95% CI 1.37–3.07) for current users of E-alone and 8.65 (95% CI 5.45–13.70) for current users of E+P. Using women who had ceased to take hormonal medication for 6 years or more as the reference group, the adjusted HRs were significantly elevated and greater than current users and women who had discontinued hormonal medication for less than 6 years. Current users of either E-alone or E+P have an increased risk for invasive breast cancer in Taiwan, and precautions should be taken when such agents are prescribed.Keywords
This publication has 28 references indexed in Scilit:
- Estrogen Alone in Postmenopausal Women and Breast Cancer Detection by Means of Mammography and Breast BiopsyJournal of Clinical Oncology, 2010
- Comparative analysis of breast cancer risk factors among hispanic and non‐hispanic white womenCancer, 2010
- Mitogen‐activated protein kinase (MAPK) pathway mediates the oestrogen‐like activities of ginsenoside Rg1 in human breast cancer (MCF‐7) cellsBritish Journal of Pharmacology, 2009
- The prescribing of Chinese herbal products in Taiwan: a cross‐sectional analysis of the national health insurance reimbursement databasePharmacoepidemiology and Drug Safety, 2008
- How the Women’s Health Initiative (WHI) Influenced Physicians’ Practice and AttitudesJournal of General Internal Medicine, 2007
- Hormone replacement therapy in relation to breast carcinoma incidence rate ratiosCancer, 2004
- Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in EuropeInternational Journal of Cancer, 2004
- Breast cancer and hormone-replacement therapy: the Million Women StudyThe Lancet, 2003
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJama-Journal Of The American Medical Association, 2002